☆ 4.5 Article

Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis

REGIONAL ANESTHESIA AND PAIN MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Intranasal ketamine for acute cluster headache attacks-Results from a proof-of-concept open-label trial

Anja S. Petersen et al.

Summary: This study investigated the safety and efficacy of intranasal ketamine for treating a single CH attack. Results showed a significant reduction in pain intensity at 30 minutes after treatment, indicating that intranasal ketamine may be an effective acute treatment for CH and should be further tested in a larger controlled design to confirm its benefits.

HEADACHE (2022)

Add to Collection

Article Dentistry, Oral Surgery & Medicine

Comparison of the efficacy of intranasal ketamine versus intravenous ketorolac on acute non-traumatic headaches: a randomized double-blind clinical trial

Hooman Rafiei Sarvari et al.

Summary: This study compared the efficacy of intranasal ketamine and intravenous ketorolac on acute non-traumatic headaches. The results showed that intranasal ketamine had a more significant analgesic effect in a short time.

HEAD & FACE MEDICINE (2022)

Add to Collection

Review Clinical Neurology

Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs

Andrew Lofts et al.

Summary: Intranasal drug delivery to the brain shows potential for treating neurological and psychiatric illnesses, but challenges remain. This review discusses the current understanding of this drug delivery pathway and addresses barriers to drug transport. It also explores the development of nanoparticle systems for delivering drugs to the brain.

CNS DRUGS (2022)

Add to Collection

Review Clinical Neurology

Ketamine in the Past, Present, and Future: Mechanisms, Metabolites, and Toxicity

Eric S. Schwenk et al.

Summary: Ketamine's analgesic and antidepressant effects may involve multiple pathways, including its metabolites. While animal studies suggest neurotoxicity, its role in nociplastic pain paradigm is still being elucidated. Future research will continue to define ketamine's role in clinical medicine, with lacking evidence of neurotoxicity in humans.

CURRENT PAIN AND HEADACHE REPORTS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Ketamine for Refractory Chronic Migraine: An Observational Pilot Study and Metabolite Analysis

Eric S. Schwenk et al.

Summary: Patients with refractory chronic migraine who have failed multiple medications may benefit from aggressive intravenous therapy using lidocaine and (R,S)-ketamine infusions, as both have shown short-term analgesic effects. Analysis of ketamine metabolites revealed that (2R,6R)-hydroxynorketamine is the primary metabolite during infusion, consistent with previous studies. While ketamine showed a slightly greater decrease in pain compared to lidocaine, the clinical significance of this difference is minimal.

JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Add to Collection

Review Neurosciences

Ketamine: Neuroprotective or Neurotoxic?

Divya Choudhury et al.

Summary: Ketamine, a non-competitive NMDAR antagonist, has been used as an intravenous anesthetic since the 1970s and is now being explored for its rapid antidepressant effects in treating various neuropsychiatric syndromes. Studies have shown that ketamine exhibits both neurotoxic and neuroprotective properties depending on the context, affecting intracellular signaling pathways in complex ways. It acts as a powerful activator of neurotrophic signaling cascades at subanesthetic doses, showcasing contrasting neuroprotective and neurotoxic characteristics.

FRONTIERS IN NEUROSCIENCE (2021)

Add to Collection

Review Medicine, General & Internal

Efficacy and Safety of Intranasal Ketamine for Acute Pain Management in the Emergency Setting: A Systematic Review and Meta-Analysis

Yee Sin Seak et al.

Summary: This study found that intranasal ketamine is non-inferior to IV analgesics in managing acute pain in adults in the emergency department, with good safety profile.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Review Clinical Neurology

Intranasal Ketamine for Abortive Migraine Therapy in Pediatric Patients: A Single-Center Review

Adrian L. Turner et al.

PEDIATRIC NEUROLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Pharmacokinetics, absolute bioavailability and tolerability of ketamine after intranasal administration to dexmedetomidine sedated dogs

Lise Vlerick et al.

PLOS ONE (2020)

Add to Collection

Article Clinical Neurology

Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations

Rafia Shafqat et al.

JOURNAL OF PAIN RESEARCH (2020)

Add to Collection

Article Clinical Neurology

European headache federation consensus on the definition of resistant and refractory migraine Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)

Simona Sacco et al.

JOURNAL OF HEADACHE AND PAIN (2020)

Add to Collection

Article Pharmacology & Pharmacy

Hydroxynorketamine Blocks N-Methyl-D-Aspartate Receptor Currents by Binding to Closed Receptors

Jamie A. Abbott et al.

MOLECULAR PHARMACOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin

Toshihiko Tashima

MOLECULES (2020)

Add to Collection

Article Emergency Medicine

THE THINK (TREATMENT OF HEADACHE WITH INTRANASAL KETAMINE) TRIAL: A RANDOMIZED CONTROLLED TRIAL COMPARING INTRANASAL KETAMINE WITH INTRAVENOUS METOCLOPRAMIDE

Trisha Benish et al.

JOURNAL OF EMERGENCY MEDICINE (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Nasal Delivery Devices: A Comparative Study on Cadaver Model

Antonio Moffa et al.

BIOMED RESEARCH INTERNATIONAL (2019)

Add to Collection

Article Psychiatry

Brain penetration of ketamine: Intranasal delivery VS parenteral routes of administraion

Vivian Naidoo et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2019)

Add to Collection

Article Computer Science, Interdisciplinary Applications

The REDCap consortium: Building an international community of software platform partners

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2019)

Add to Collection

Review Pharmacology & Pharmacy

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

Panos Zanos et al.

PHARMACOLOGICAL REVIEWS (2018)

Add to Collection

Editorial Material Anesthesiology

2018: A State-of-the-Journal Report

Marc A. Huntoon

REGIONAL ANESTHESIA AND PAIN MEDICINE (2018)

Add to Collection

Article Anesthesiology

Ketamine for Refractory Headache A Retrospective Analysis

Eric S. Schwenk et al.

REGIONAL ANESTHESIA AND PAIN MEDICINE (2018)

Add to Collection

Article Clinical Neurology

Ketamine Infusions for Treatment Refractory Headache

Jared L. Pomeroy et al.

HEADACHE (2017)

Add to Collection

Article Chemistry, Analytical

Quantitative chiral and achiral determination of ketamine and its metabolites by LC-MS/MS in human serum, urine and fecal samples

Mahmoud Hasan et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)

Add to Collection

Article Multidisciplinary Sciences

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Panos Zanos et al.

NATURE (2016)

Add to Collection

Article Clinical Neurology

A randomized controlled trial of intranasal ketamine in migraine with prolonged aura

Shazia K. Afridi et al.

NEUROLOGY (2013)

Add to Collection

Review Instruments & Instrumentation

Current understanding of nasal morphology and physiology as a drug delivery target

Julie D. Suman

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2013)

Add to Collection

Editorial Material Emergency Medicine

The Taming of Ketamine-40 Years Later

Steven M. Green et al.

ANNALS OF EMERGENCY MEDICINE (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.